Françoise Rothé

7.1k total citations
71 papers, 2.9k citations indexed

About

Françoise Rothé is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Françoise Rothé has authored 71 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 37 papers in Cancer Research and 19 papers in Molecular Biology. Recurrent topics in Françoise Rothé's work include Cancer Genomics and Diagnostics (25 papers), Cancer Cells and Metastasis (13 papers) and HER2/EGFR in Cancer Research (13 papers). Françoise Rothé is often cited by papers focused on Cancer Genomics and Diagnostics (25 papers), Cancer Cells and Metastasis (13 papers) and HER2/EGFR in Cancer Research (13 papers). Françoise Rothé collaborates with scholars based in Belgium, Italy and United States. Françoise Rothé's co-authors include Christos Sotiriou, Martine Piccart, Michail Ignatiadis, Christine Desmedt, David Venet, Denis Larsimont, Yacine Barèche, Naı̈ma Kheddoumi, Philippe Aftimos and Hussein Fayyad‐Kazan and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Françoise Rothé

66 papers receiving 2.9k citations

Peers

Françoise Rothé

ONCOL

PRM

IMMUN

Erica L. Carpenter United States

Heng‐Huan Lee United States

Oscar Krijgsman Netherlands

Marco Gerlinger United Kingdom

Yan‐Gao Man United States

Ghizlane Rouas Belgium

Li‐Xu Yan China

Emi Sei United States

Sean P. Pitroda United States

Farbod Darvishian United States

Erica L. Carpenter United States

Françoise Rothé

1.1k ×0.7

ONCOL

1.1k ×0.8

1.4k ×1.2

620 ×1.1

PRM

473 ×1.0

IMMUN

Citations per year, relative to Françoise Rothé Françoise Rothé (= 1×) peers Erica L. Carpenter

Countries citing papers authored by Françoise Rothé

Since Specialization

Citations

This map shows the geographic impact of Françoise Rothé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Rothé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Rothé more than expected).

Fields of papers citing papers by Françoise Rothé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Rothé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Rothé. The network helps show where Françoise Rothé may publish in the future.

Co-authorship network of co-authors of Françoise Rothé

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Rothé. A scholar is included among the top collaborators of Françoise Rothé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Rothé. Françoise Rothé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marta, Guilherme Nader, et al.. (2025). PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial. European Journal of Nuclear Medicine and Molecular Imaging. 53(5). 3152–3161.

Rouas, G., et al.. (2024). 43P Deciphering spatial expression of trop-2, HER2, and AR: Towards customized treatments in triple-negative breast cancer. ESMO Open. 9. 103050–103050. 1 indexed citations

Venet, David, Ghizlane Rouas, Xiaoxiao Wang, et al.. (2024). Spatial transcriptomic and proteomic insight into Trop-2, HER2, and AR expression: A pathway to tailored therapies in triple-negative breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e12576–e12576. 2 indexed citations

Rediti, Mattia, Danai Fimereli, Zéna Wimana, et al.. (2024). Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial. Clinical Cancer Research. 31(1). 110–121. 3 indexed citations

Rediti, Mattia, David Venet, Marion Maetens, et al.. (2024). Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial. Nature Communications. 15(1). 10402–10402. 3 indexed citations

Rediti, Mattia, David Venet, Samira Majjaj, et al.. (2023). Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22–00. Clinical Cancer Research. 29(23). 4908–4919. 7 indexed citations

Wang, Xiaoxiao, L. Collet, Mattia Rediti, et al.. (2023). Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. Journal of Clinical Medicine. 12(3). 953–953. 33 indexed citations

Agostinetto, Elisa, Matteo Lambertini, Françoise Rothé, et al.. (2022). Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse. JCO Precision Oncology. 6(6). e2200148–e2200148. 48 indexed citations

Rothé, Françoise, David Venet, Dieter Peeters, et al.. (2022). Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis. npj Breast Cancer. 8(1). 79–79. 15 indexed citations

10.

Wang, Xiaoxiao, David Venet, Denis Larsimont, et al.. (2022). 1711P Spatial transcriptomics reveals substantial heterogeneity in TNBC tumor and stroma compartments with potential clinical implications. Annals of Oncology. 33. S1321–S1322. 1 indexed citations

11.

Gombos, Andrea, David Venet, Lieveke Ameye, et al.. (2021). FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. npj Breast Cancer. 7(1). 125–125. 14 indexed citations

12.

Richard, François, Samira Majjaj, David Venet, et al.. (2020). Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clinical Cancer Research. 26(23). 6254–6265. 19 indexed citations

13.

Hunter, Francis W., Barbara Lipert, Françoise Rothé, et al.. (2019). Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer. British Journal of Cancer. 122(5). 603–612. 213 indexed citations

14.

Denis, Hélène, Benjamin Delatte, Sarah Dedeurwaerder, et al.. (2015). MicroRNAs regulate KDM5 histone demethylases in breast cancer cells. Molecular BioSystems. 12(2). 404–413. 35 indexed citations

15.

Sonnenblick, Amir, Sylvain Brohée, Debora Fumagalli, et al.. (2015). Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer. BMC Medicine. 13(1). 177–177. 44 indexed citations

16.

Sonnenblick, Amir, Sylvain Brohée, Debora Fumagalli, et al.. (2015). Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial. Oncotarget. 6(30). 30306–30316. 14 indexed citations

17.

Fimereli, Danai, David Gacquer, Debora Fumagalli, et al.. (2015). No significant viral transcription detected in whole breast cancer transcriptomes. BMC Cancer. 15(1). 147–147. 17 indexed citations

18.

Rothé, Françoise, Diether Lambrechts, Delphine Vincent, et al.. (2014). Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer. Annals of Oncology. 25(10). 1959–1965. 188 indexed citations

19.

Haibe‐Kains, Benjamin, Christine Desmedt, Françoise Rothé, et al.. (2010). A fuzzy gene expression-based computational approach improves breast cancer prognostication. Genome biology. 11(2). R18–R18. 38 indexed citations

20.

Rothé, Françoise, Cyril Gueydan, Eric Bellefroid, Georges Huez, & Véronique Kruys. (2006). Identification of FUSE-binding proteins as interacting partners of TIA proteins. Biochemical and Biophysical Research Communications. 343(1). 57–68. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact